Dr. Riedl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19 Bradhurst Ave Ste 1200
Hawthorne, NY 10532Phone+1 914-347-3171Fax+1 914-347-3172
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 2012 - 2014
University of Vienna Faculty of MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2015 - 2027
NJ State Medical License 2017 - 2025- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- Many
Clinical Trials
- Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer Start of enrollment: 2019 Aug 09
Publications & Presentations
PubMed
- 9 citationsProspective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis.Amy R Deipolyi, C Bryce Johnson, Christopher C Riedl, Henry Kunin, Stephen B Solomon
Radiology. 2023-01-01 - 19 citationsProspective testing of clinical Cerenkov luminescence imaging against standard-of-care nuclear imaging for tumour location.Edwin C Pratt, Magdalena Skubal, Benedict Mc Larney, Pamela Causa-Andrieu, Sudeep Das
Nature Biomedical Engineering. 2022-05-01 - 6 citationsTreatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE.Nitya Raj, Kelley Coffman, Tiffany Le, Richard Kinh Gian Do, Johnathan Rafailov
Neuroendocrinology. 2022-01-01
Press Mentions
FDG-PET/CT Shows Promise for Breast Cancer Patients Younger Than 40October 1st, 2014
Other Languages
- German, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
